Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation (Tables)

v3.22.1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Summary of Stock-Based Compensation Expense
A summary of the Company’s stock-based compensation expense as recognized on the condensed consolidated statements of operations is presented in thousands below:
Three months ended March 31,
2022 2021
Cost of revenue $ 517  $ 74 
Research and development 1,400  269 
Sales and marketing 2,258  420 
General and administrative 2,285  761 
Total stock-based compensation $ 6,460  $ 1,524 
Summary of Unvested RSU Activity
A summary of the Company’s unvested RSUs and activity for the three months ended March 31, 2022 is as follows:

Shares Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2021 1,702,724  $ 27.49 
Granted 1,737,772  13.25 
Vested —  — 
Canceled (31,361) 24.87 
Outstanding at March 31, 2022 3,409,135  20.26 
Summary of Plan Activity
A summary of the Company’s stock option activity and related information for the three months ended March 31, 2022 is as follows:
Number of
Awards
Outstanding
Weighted-
Average
Exercise Price
Weighted
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value (in
thousands)
Balance at December 31, 2021
14,219,587  $ 5.10  6.4 $ 306,981 
Options granted —  — 
Options exercised (1,602,727) 1.36 
Options forfeited (96,923) 5.83 
Balance at March 31, 2022
12,519,937  5.57  6.8 206,124 
As of March 31, 2022:
Vested and exercisable 8,243,002  3.53  5.9 151,553